Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more ...

The biggest businesses in America have had a great year, with stock prices reaching all-time highs due to growing profits and enthusiasm for artificial intelligence. On the other hand, many small ...

Holdings within consumer discretionary and financials along with relative underweights to several mega-cap companies detracted from returns. Security selection within health care and select ...